Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin in Early Parkinson's Disease
NCT06951334Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of vildagliptin in Parkinson's disease (PD) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Movement Disorder Society-Unified Parkinson's Disease Rating Scale Part III at 12 months. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
vildagliptin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06951334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06951334.